Kezar Life Sciences (KZR) Equity Ratio (2021 - 2025)
Historic Equity Ratio for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to 0.85.
- Kezar Life Sciences' Equity Ratio rose 393.22% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year increase of 393.22%. This contributed to the annual value of 0.81 for FY2024, which is 468.75% down from last year.
- Per Kezar Life Sciences' latest filing, its Equity Ratio stood at 0.85 for Q3 2025, which was up 393.22% from 0.84 recorded in Q2 2025.
- Kezar Life Sciences' Equity Ratio's 5-year high stood at 0.94 during Q2 2022, with a 5-year trough of 0.81 in Q4 2024.
- Over the past 5 years, Kezar Life Sciences' median Equity Ratio value was 0.88 (recorded in 2023), while the average stood at 0.88.
- In the last 5 years, Kezar Life Sciences' Equity Ratio plummeted by 676.66% in 2023 and then skyrocketed by 393.22% in 2025.
- Kezar Life Sciences' Equity Ratio (Quarter) stood at 0.9 in 2021, then fell by 0.28% to 0.9 in 2022, then dropped by 5.89% to 0.85 in 2023, then decreased by 4.69% to 0.81 in 2024, then rose by 5.07% to 0.85 in 2025.
- Its last three reported values are 0.85 in Q3 2025, 0.84 for Q2 2025, and 0.82 during Q1 2025.